PD-L1 expression in Human Heart lysate analyzed by western blot. Cells were lysed in RIPA buffer and 35µg protein was run per lane. Primary antibody incubation was performed with Anti-PD-L1 Antibody (A82538) at 0.01µg/ml and detected by chemiluminescence.
PD-L1 expression in U2OS cell lysate analyzed by western blot. Cells were lysed in RIPA buffer and 35µg protein was run per lane. Primary antibody incubation was performed with Anti-PD-L1 Antibody (A82538) at 0.1µg/ml and detected by chemiluminescence.
PD-L1 expression in A431 cells analyzed by immunofluorescence. Cells were permeabilized with 0.15% Triton. Staining was performed with Anti-PD-L1 Antibody (A82538) at 10µg/ml for 1 hour and Alexa Fluor 488 secondary antibody at 2µg/ml. Cytoplasmic staining shown and nuclei were stained with DAPI (blue). Negative control: Goat IgG Isotype Control at 10µg/ml followed by Alexa Fluor 488 secondary antibody at 2µg/ml.
PD-L1 expression in U2OS cells analyzed by immunofluorescence. Cells were permeabilized with 0.15% Triton. Staining was performed with Anti-PD-L1 Antibody (A82538) at 10µg/ml for 1 hour and Alexa Fluor 488 secondary antibody at 2µg/ml. Cytoplasmic and plasma membrane staining shown and nuclei were stained with DAPI (blue). Negative control: Goat IgG Isotype Control at 10µg/ml followed by Alexa Fluor 488 secondary antibody at 2µg/ml.
PD-L1 expression in Jurkat cells (blue line) analyzed by flow cytometry. Cells were fixed in PFA and permeabilized with 0.5% Triton. Staining was performed with Anti-PD-L1 Antibody (A82538) at 10µg/ml for 1 hour and Alexa Fluor 488 secondary antibody at 1µg/ml. Negative Control: Goat IgG Isotype Control (black line) followed by Alexa Fluor 488 secondary antibody.
Recombinant rat monoclonal antibody to PD-L1 [10F9G2] for use as a research grade 10F9G2 biosimila for WB, Flow Cytometry, ICC/IF, IHC-F, in vivo PD-L1 blockade, in vitro PD-L1 blockade and ICC/IF.
Recombinant human monoclonal antibody to PD-L1 for use as a research grade Durvalumab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.
Recombinant human monoclonal antibody to PD-L1 for use as a research grade Avelumab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.
Recombinant human monoclonal antibody to PD-L1 for use as a research grade Manelimab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.
Recombinant rat monoclonal antibody to PD-L1 [10F9G2] for use as a research grade 10F9G2 biosimila for WB, Flow Cytometry, ICC/IF, IHC-F, in vivo PD-L1 blockade, in vitro PD-L1 blockade and ICC/IF.
Recombinant human monoclonal antibody to PD-L1 for use as a research grade Durvalumab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.
Recombinant human monoclonal antibody to PD-L1 for use as a research grade Avelumab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.
Recombinant human monoclonal antibody to PD-L1 for use as a research grade Manelimab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.